• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease.欧洲心脏病学会 0/1 小时算法在已知冠心病患者中应用高敏心肌肌钙蛋白 T 的性能。
JAMA Cardiol. 2023 Apr 1;8(4):347-356. doi: 10.1001/jamacardio.2023.0031.
2
Performance of the European Society of Cardiology 0/1-hour algorithm with high-sensitivity cardiac troponin T at 90 days among patients with known coronary artery disease.已知冠状动脉疾病患者中,欧洲心脏病学会0/1小时高敏心肌肌钙蛋白T算法在90天时的表现。
Am J Emerg Med. 2024 May;79:111-115. doi: 10.1016/j.ajem.2024.02.029. Epub 2024 Feb 23.
3
European Society of Cardiology 0/1-hour algorithm (high-sensitivity cardiac troponin T) performance across distinct age groups.欧洲心脏病学会 0/1 小时算法(高敏心肌肌钙蛋白 T)在不同年龄组的性能。
Heart. 2024 May 23;110(12):838-845. doi: 10.1136/heartjnl-2023-323621.
4
Sex and race differences in the performance of the European Society of Cardiology 0/1-h algorithm with high-sensitivity troponin T.高敏肌钙蛋白 T 的欧洲心脏病学会 0/1-h 算法在性别和种族差异中的表现。
Clin Cardiol. 2024 Feb;47(2):e24199. doi: 10.1002/clc.24199. Epub 2023 Dec 13.
5
Performance of the 0/2-hour high-sensitivity cardiac troponin T diagnostic protocol in a multisite United States cohort.0/2 小时高敏心肌肌钙蛋白 T 诊断方案在多中心美国队列中的表现。
Acad Emerg Med. 2024 Mar;31(3):239-248. doi: 10.1111/acem.14827. Epub 2024 Jan 8.
6
Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort.美国多中心队列中高敏心肌肌钙蛋白T检测策略与临床变量的诊断效能
Circulation. 2021 Apr 27;143(17):1659-1672. doi: 10.1161/CIRCULATIONAHA.120.049298. Epub 2021 Jan 21.
7
Use of historical high-sensitivity cardiac troponin T levels to rule out myocardial infarction.应用高敏心肌肌钙蛋白 T 的历史数据水平排除心肌梗死。
Open Heart. 2021 May;8(1). doi: 10.1136/openhrt-2021-001682.
8
Outcomes of European Society of Cardiology 0/1-h algorithm with high-sensitivity cardiac troponin T among patients with coronary artery disease.在患有冠状动脉疾病的患者中,采用欧洲心脏病学会 0/1-h 算法和高敏心肌肌钙蛋白 T 的结果。
Catheter Cardiovasc Interv. 2023 Dec;102(7):1155-1161. doi: 10.1002/ccd.30905. Epub 2023 Nov 5.
9
A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT).一项在疑似急性冠状动脉综合征患者中应用 1 小时肌钙蛋白 T 方案的随机试验:高敏肌钙蛋白 T 在急诊科快速评估疑似急性冠状动脉综合征的研究(RAPID-TnT)。
Circulation. 2019 Nov 5;140(19):1543-1556. doi: 10.1161/CIRCULATIONAHA.119.042891. Epub 2019 Sep 3.
10
Validation of the ACC Expert Consensus Decision Pathway for Patients With Chest Pain.用于胸痛患者的 ACC 专家共识决策路径的验证。
J Am Coll Cardiol. 2024 Apr 2;83(13):1181-1190. doi: 10.1016/j.jacc.2024.02.004. Epub 2024 Mar 25.

引用本文的文献

1
Analytical Performance of the New Sysmex High-Sensitivity Troponin T Assay.Sysmex新型高敏肌钙蛋白T检测方法的分析性能
Diagnostics (Basel). 2025 Jul 22;15(15):1838. doi: 10.3390/diagnostics15151838.
2
Multisite Validation of a Strategy to Identify Very Low Risk Emergency Department Patients Without Troponin.一种用于识别无肌钙蛋白的极低风险急诊科患者策略的多中心验证
JACC Adv. 2025 Jun 18;4(7):101913. doi: 10.1016/j.jacadv.2025.101913.
3
Utilization and outcomes of single-troponin discharge from the emergency department in a low-risk population.低风险人群急诊科单次肌钙蛋白检测的应用及结果
Glob Cardiol Sci Pract. 2025 Feb 28;2025(1):e202508. doi: 10.21542/gcsp.2025.8.
4
Performance of the High-STEACS Early Rule Out Pathway Using hs-cTnT at 30 Days in a Multisite US Cohort.在美国多中心队列中,使用高敏心肌肌钙蛋白T的高STEACS早期排除途径在30天时的表现。
Circ Cardiovasc Qual Outcomes. 2025 Feb;18(2):e011084. doi: 10.1161/CIRCOUTCOMES.124.011084. Epub 2025 Jan 9.
5
High-Sensitivity Troponin: Finding a Meaningful Delta.高敏肌钙蛋白:寻找有意义的变化值
J Cardiovasc Dev Dis. 2024 Oct 11;11(10):318. doi: 10.3390/jcdd11100318.
6
The High-Sensitivity HEART Pathway Safely Reduces Hospitalizations Regardless of Sex or Race in a Multisite Prospective US Cohort.高敏心脏标志物检测路径可安全减少住院,无论患者性别或种族如何——一项多中心前瞻性美国队列研究
Clin Cardiol. 2024 Oct;47(10):e70027. doi: 10.1002/clc.70027.
7
A multicenter prospective study on the ESC algorithm for the early diagnosis of non-ST-elevation myocardial infarction.一项关于ESC算法用于非ST段抬高型心肌梗死早期诊断的多中心前瞻性研究。
iScience. 2024 Aug 5;27(9):110643. doi: 10.1016/j.isci.2024.110643. eCollection 2024 Sep 20.
8
Sex-specific high-sensitivity troponin T cut-points have similar safety but lower efficacy than overall cut-points in a multisite U.S. cohort.在美国一个多中心队列中,性别特异性高敏肌钙蛋白T切点与总体切点相比具有相似的安全性,但有效性较低。
Acad Emerg Med. 2025 Jan;32(1):45-53. doi: 10.1111/acem.15014. Epub 2024 Sep 2.
9
Diagnostic Performance of High-Sensitivity Cardiac Troponin I in a Multicenter U.S. Emergency Department Cohort.高敏心肌肌钙蛋白I在美国多中心急诊科队列中的诊断性能
JACC Adv. 2023 Aug 17;2(7):100558. doi: 10.1016/j.jacadv.2023.100558. eCollection 2023 Sep.
10
High-Sensitivity Troponin in Patients With Cancer: Sensitive But Not Specific.癌症患者的高敏肌钙蛋白:敏感但不特异。
JACC CardioOncol. 2023 Oct 17;5(5):610-612. doi: 10.1016/j.jaccao.2023.09.001. eCollection 2023 Oct.

本文引用的文献

1
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估与诊断指南:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2021 Nov 30;78(22):e187-e285. doi: 10.1016/j.jacc.2021.07.053. Epub 2021 Oct 28.
2
Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort.美国多中心队列中高敏心肌肌钙蛋白T检测策略与临床变量的诊断效能
Circulation. 2021 Apr 27;143(17):1659-1672. doi: 10.1161/CIRCULATIONAHA.120.049298. Epub 2021 Jan 21.
3
The 'Ten Commandments' for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会(ESC)非持续性ST段抬高型急性冠状动脉综合征患者管理指南的“十诫”
Eur Heart J. 2020 Oct 1;41(37):3495-3497. doi: 10.1093/eurheartj/ehaa624.
4
Performance of the European Society of Cardiology 0/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin: Systematic review and meta-analysis.欧洲心脏病学会0/1小时算法在高敏心肌肌钙蛋白诊断心肌梗死中的应用:系统评价和荟萃分析
Eur Heart J Acute Cardiovasc Care. 2021 May 11;10(3):279–286. doi: 10.1177/2048872620935399. Epub 2020 Jun 29.
5
Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study.新型高敏心肌肌钙蛋白 I 检测在 0/1 小时和 0/2 至 3 小时评估急性心肌梗死中的性能:来自 HIGH-US 研究的结果。
Ann Emerg Med. 2020 Jul;76(1):1-13. doi: 10.1016/j.annemergmed.2019.12.008. Epub 2020 Feb 8.
6
Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction.ESC 0/1 小时算法在疑似心肌梗死患者中的应用结果。
J Am Coll Cardiol. 2019 Jul 30;74(4):483-494. doi: 10.1016/j.jacc.2019.05.046.
7
Analytical performance evaluation of the Elecsys® Troponin T Gen 5 STAT assay.Elecsys® Troponin T Gen 5 STAT 检测试剂分析性能评估。
Clin Chim Acta. 2019 Aug;495:522-528. doi: 10.1016/j.cca.2019.05.026. Epub 2019 May 30.
8
Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel.向高敏肌钙蛋白检测过渡的机构的建议:JACC 科学专家小组。
J Am Coll Cardiol. 2019 Mar 12;73(9):1059-1077. doi: 10.1016/j.jacc.2018.12.046. Epub 2019 Feb 21.
9
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.《2019年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
10
Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays.使用敏感心肌肌钙蛋白检测法早期诊断心肌梗死
Clin Chem. 2019 Mar;65(3):490-491. doi: 10.1373/clinchem.2018.298638. Epub 2019 Jan 7.

欧洲心脏病学会 0/1 小时算法在已知冠心病患者中应用高敏心肌肌钙蛋白 T 的性能。

Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease.

机构信息

Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.

出版信息

JAMA Cardiol. 2023 Apr 1;8(4):347-356. doi: 10.1001/jamacardio.2023.0031.

DOI:10.1001/jamacardio.2023.0031
PMID:36857071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9979014/
Abstract

IMPORTANCE

The European Society of Cardiology (ESC) 0/1-hour algorithm is a validated high-sensitivity cardiac troponin (hs-cTn) protocol for emergency department patients with possible acute coronary syndrome. However, limited data exist regarding its performance in patients with known coronary artery disease (CAD; prior myocardial infarction [MI], coronary revascularization, or ≥70% coronary stenosis).

OBJECTIVE

To evaluate and compare the diagnostic performance of the ESC 0/1-hour algorithm for 30-day cardiac death or MI among patients with and without known CAD and determine if the algorithm could achieve the negative predictive value rule-out threshold of 99% or higher.

DESIGN, SETTING, AND PARTICIPANTS: This was a preplanned subgroup analysis of the STOP-CP prospective multisite cohort study, which was conducted from January 25, 2017, through September 6, 2018, at 8 emergency departments in the US. Patients 21 years or older with symptoms suggestive of acute coronary syndrome without ST-segment elevation on initial electrocardiogram were included. Analysis took place between February and December 2022.

INTERVENTIONS/EXPOSURES: Participants with 0- and 1-hour high-sensitivity cardiac troponin T (hs-cTnT) measures were stratified into rule-out, observation, and rule-in zones using the ESC 0/1-hour hs-cTnT algorithm.

MAIN OUTCOMES AND MEASURES

Cardiac death or MI at 30 days determined by expert adjudicators.

RESULTS

During the study period, 1430 patients were accrued. In the cohort, 775 individuals (54.2%) were male, 826 (57.8%) were White, and the mean (SD) age was 57.6 (12.8) years. At 30 days, cardiac death or MI occurred in 183 participants (12.8%). Known CAD was present in 449 (31.4%). Among patients with known CAD, the ESC 0/1-hour algorithm classified 178 of 449 (39.6%) into the rule-out zone compared with 648 of 981 (66.1%) without CAD (P < .001). Among rule-out zone patients, 30-day cardiac death or MI occurred in 6 of 178 patients (3.4%) with known CAD and 7 of 648 (1.1%) without CAD (P < .001). The negative predictive value for 30-day cardiac death or MI was 96.6% (95% CI, 92.8-98.8) among patients with known CAD and 98.9% (95% CI, 97.8-99.6) in patients without known CAD (P = .04).

CONCLUSIONS AND RELEVANCE

Among patients with known CAD, the ESC 0/1-hour hs-cTnT algorithm was unable to safely exclude 30-day cardiac death or MI. This suggests that clinicians should be cautious if using the algorithm in patients with known CAD. The negative predictive value was significantly higher in patients without a history of CAD but remained less than 99%.

摘要

重要性

欧洲心脏病学会(ESC)0/1 小时算法是一种经过验证的用于急诊科可能发生急性冠状动脉综合征的患者的高敏心肌肌钙蛋白(hs-cTn)方案。然而,关于该方案在已知冠心病(CAD;既往心肌梗死[MI]、冠状动脉血运重建或≥70%冠状动脉狭窄)患者中的表现,数据有限。

目的

评估和比较 ESC 0/1 小时算法在有和无已知 CAD 的患者中用于 30 天心脏死亡或 MI 的诊断性能,并确定该算法是否可以达到 99%或更高的阴性预测值排除阈值。

设计、设置和参与者:这是 STOP-CP 前瞻性多地点队列研究的预先计划的亚组分析,该研究于 2017 年 1 月 25 日至 2018 年 9 月 6 日在美国 8 家急诊室进行。纳入有疑似急性冠状动脉综合征症状且初始心电图无 ST 段抬高的 21 岁及以上患者。分析于 2022 年 2 月至 12 月进行。

干预措施/暴露:使用 ESC 0/1 小时 hs-cTnT 算法,将 0 小时和 1 小时高敏心肌肌钙蛋白 T(hs-cTnT)测量值的患者分层为排除、观察和纳入区。

主要结局和措施

由专家裁决确定的 30 天内的心脏死亡或 MI。

结果

在研究期间,共纳入了 1430 名患者。在队列中,775 名患者(54.2%)为男性,826 名患者(57.8%)为白人,平均(SD)年龄为 57.6(12.8)岁。在 30 天内,有 183 名患者(12.8%)发生心脏死亡或 MI。已知 CAD 存在于 449 名患者(31.4%)中。在已知 CAD 患者中,ESC 0/1 小时算法将 449 名患者中的 178 名(39.6%)分类为排除区,而 981 名患者中无 CAD 的患者为 648 名(66.1%)(P<.001)。在排除区患者中,6 名已知 CAD 患者(3.4%)和 7 名无 CAD 患者(1.1%)在 30 天内发生心脏死亡或 MI(P<.001)。已知 CAD 患者的 30 天心脏死亡或 MI 的阴性预测值为 96.6%(95%CI,92.8%-98.8%),无已知 CAD 患者为 98.9%(95%CI,97.8%-99.6%)(P=.04)。

结论和相关性

在已知 CAD 患者中,ESC 0/1 小时 hs-cTnT 算法无法安全排除 30 天心脏死亡或 MI。这表明如果在已知 CAD 患者中使用该算法,临床医生应谨慎。无 CAD 患者的阴性预测值显著较高,但仍低于 99%。